Change Makers: David Ricks Is Leading With Purpose
The real competition in medicine is not between companies. Rather it's us against disease. http://ms.spr.ly/6187jjBXl
Can You Crack the Case? Applying Advances in Pericarditis
🚨 TODAY: Earn CME credits on Linkedin and Twitter. Join our experts at 5:30 PM ET, MedscapeLIVE is hosting Can You Crack the Case? Applying Advances in Pericarditis. 📲 Click the link to secure your spot: http://ms.spr.ly/6185jnwwf
Medscape TV Presents:
Among middle-aged people without heart disease, drinking up to 3 cups of coffee per day was linked with a lower risk for stroke or death. http://ms.spr.ly/6188XAd7i #ESCCongress
Finerenone benefits patients with T2D across CKD spectrum
FIDELITY: Finerenone benefits patients with T2D across CKD spectrum. http://ms.spr.ly/6180XTWhi #ESCCongress
Medscape TV Presents: This Week in Cardiology
EMPEROR-Preserved, the LOOP study, ablate-and-pace for AF, and salt substitute and stroke: John Mandrola, MD provides a first of two ESC reviews.
http://ms.spr.ly/6182XyPSu
APAF-CRT: ‘Ablate and pace’ cuts mortality in narrow-QRS HF
When a patient has permanent AFib and advanced HF, rate control therapy is an option but an “ablate-and-pace” strategy may be better. http://ms.spr.ly/6187XGxyL #ESCCongress
Finerenone benefits patients with T2D across CKD spectrum
FIDELITY: Finerenone benefits patients with T2D across CKD spectrum. #ESCCongress
COFFEE DRINKING IN MIDLIFE TIED TO HEART BENEFITS
New study finds no adverse effects from coffee drinking on CV health + a possible benefit. http://ms.spr.ly/6185X1LDT #ESCCongress
Finerenone benefits patients with T2D across CKD spectrum
FIDELITY: Finerenone benefits patients with T2D across CKD spectrum. http://ms.spr.ly/6182XD3X2 #ESCCongress
APAF-CRT: ‘Ablate and pace’ cuts mortality in narrow-QRS HF
When a patient has permanent AFib and advanced HF, rate control therapy is an option but an “ablate-and-pace” strategy may be better. http://ms.spr.ly/6180XD338 #ESCCongress
COFFEE DRINKING IN MIDLIFE TIED TO HEART BENEFITS
New study finds no adverse effects from coffee drinking on CV health + a possible benefit. http://ms.spr.ly/6181XD3GH #ESCCongress
August 13 - This Week in Cardiology
ICYMI: @drjohnm covers COVID-19, vaccine-induced myocarditis, Watchman complications, SGLT2 inhibitors, and cardiogenic shock on a popular episode from This Week in Cardiology. 🎧
http://ms.spr.ly/6180X6mZ8
This Week in Cardiology
ICYMI: Dr John Mandrola covers COVID-19, vaccine-induced myocarditis, Watchman complications, SGLT2 inhibitors, and cardiogenic shock in This Week in Cardiology. 🎧
Medicine and the Machine Podcast
#AHA20: SOLOIST-WHF & SCORED Trial Results
SEARCH-AF Trial Results from #AHA20
In Case you Missed It.mp4
#AHA20: HFrEF Study Results
#AHA20: Evinacumab lowers LDL cholesterol
Results from the SCAPIS Study #AHA20
ALPHEUS TRIAL Results From #AHA20.
#AHA20: HFrEF Study Results
ALPHEUS TRIAL Results From #AHA20.
5 Things You Missed from #AHA20.